The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization

Mozhgan Rezaie Kanavi, Soesiawati Darjatmoko, Shoujian Wang, Amir A. Azari, Mitra Farnoodian, Jason D. Kenealey, Paul R. Van Ginkel, Daniel Albert, Nader Sheibani, Arthur S. Polans

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The objective of this study was to determine whether resveratrol or a defined, reconstituted grape powder can attenuate the formation of new blood vessels in a mouse model of choroidal neovascularization (CNV). To accomplish this objective, C57BL/6J mice were randomized into control or treatment groups which received either resveratrol or grape powder by daily oral gavage, resveratrol or grape powder delivered ad libitum through the drinking water, or resveratrol by slow release via implanted osmotic pumps. A laser was used to rupture Bruch's membrane to induce CNV which was then detected in sclerochoroidal eyecups stained with antibodies against intercellular adhesion molecule-2. CNV area was measured using fluorescence microscopy and Image J software. Ad libitum delivery of both resveratrol and grape powder was shown to significantly reduce the extent of CNV by 68% and 57%, respectively. Parallel experiments conducted in vitro demonstrated that resveratrol activates p53 and inactivates Akt/protein kinase B in choroidal endothelial cells, contributing to its anti-proliferative and anti-migratory properties. In addition resveratrol was shown to inhibit the formation of endothelial cell networks, augmenting its overall anti-angiogenic effects. The non-toxic nature of resveratrol makes it an especially attractive candidate for the prevention and/or treatment of CNV.

Original languageEnglish (US)
Pages (from-to)17578-17603
Number of pages26
JournalMolecules
Volume19
Issue number11
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

angiogenesis
Choroidal Neovascularization
blood vessels
Vitis
Blood vessels
Powders
Blood Vessels
mice
delivery
Endothelial cells
drinking
antibodies
Endothelial Cells
Bruch Membrane
adhesion
Proto-Oncogene Proteins c-akt
resveratrol
Fluorescence microscopy
pumps
Cell Adhesion Molecules

Keywords

  • Age-related macular degeneration
  • Angiogenesis
  • Choroidal neovascularization
  • Grape constituents
  • Natural products
  • Resveratrol

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Kanavi, M. R., Darjatmoko, S., Wang, S., Azari, A. A., Farnoodian, M., Kenealey, J. D., ... Polans, A. S. (2014). The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. Molecules, 19(11), 17578-17603. https://doi.org/10.3390/molecules191117578

The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. / Kanavi, Mozhgan Rezaie; Darjatmoko, Soesiawati; Wang, Shoujian; Azari, Amir A.; Farnoodian, Mitra; Kenealey, Jason D.; Van Ginkel, Paul R.; Albert, Daniel; Sheibani, Nader; Polans, Arthur S.

In: Molecules, Vol. 19, No. 11, 01.11.2014, p. 17578-17603.

Research output: Contribution to journalArticle

Kanavi, MR, Darjatmoko, S, Wang, S, Azari, AA, Farnoodian, M, Kenealey, JD, Van Ginkel, PR, Albert, D, Sheibani, N & Polans, AS 2014, 'The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization', Molecules, vol. 19, no. 11, pp. 17578-17603. https://doi.org/10.3390/molecules191117578
Kanavi, Mozhgan Rezaie ; Darjatmoko, Soesiawati ; Wang, Shoujian ; Azari, Amir A. ; Farnoodian, Mitra ; Kenealey, Jason D. ; Van Ginkel, Paul R. ; Albert, Daniel ; Sheibani, Nader ; Polans, Arthur S. / The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. In: Molecules. 2014 ; Vol. 19, No. 11. pp. 17578-17603.
@article{379b6cde58044921b1475dfbea8233ac,
title = "The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization",
abstract = "The objective of this study was to determine whether resveratrol or a defined, reconstituted grape powder can attenuate the formation of new blood vessels in a mouse model of choroidal neovascularization (CNV). To accomplish this objective, C57BL/6J mice were randomized into control or treatment groups which received either resveratrol or grape powder by daily oral gavage, resveratrol or grape powder delivered ad libitum through the drinking water, or resveratrol by slow release via implanted osmotic pumps. A laser was used to rupture Bruch's membrane to induce CNV which was then detected in sclerochoroidal eyecups stained with antibodies against intercellular adhesion molecule-2. CNV area was measured using fluorescence microscopy and Image J software. Ad libitum delivery of both resveratrol and grape powder was shown to significantly reduce the extent of CNV by 68{\%} and 57{\%}, respectively. Parallel experiments conducted in vitro demonstrated that resveratrol activates p53 and inactivates Akt/protein kinase B in choroidal endothelial cells, contributing to its anti-proliferative and anti-migratory properties. In addition resveratrol was shown to inhibit the formation of endothelial cell networks, augmenting its overall anti-angiogenic effects. The non-toxic nature of resveratrol makes it an especially attractive candidate for the prevention and/or treatment of CNV.",
keywords = "Age-related macular degeneration, Angiogenesis, Choroidal neovascularization, Grape constituents, Natural products, Resveratrol",
author = "Kanavi, {Mozhgan Rezaie} and Soesiawati Darjatmoko and Shoujian Wang and Azari, {Amir A.} and Mitra Farnoodian and Kenealey, {Jason D.} and {Van Ginkel}, {Paul R.} and Daniel Albert and Nader Sheibani and Polans, {Arthur S.}",
year = "2014",
month = "11",
day = "1",
doi = "10.3390/molecules191117578",
language = "English (US)",
volume = "19",
pages = "17578--17603",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "11",

}

TY - JOUR

T1 - The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization

AU - Kanavi, Mozhgan Rezaie

AU - Darjatmoko, Soesiawati

AU - Wang, Shoujian

AU - Azari, Amir A.

AU - Farnoodian, Mitra

AU - Kenealey, Jason D.

AU - Van Ginkel, Paul R.

AU - Albert, Daniel

AU - Sheibani, Nader

AU - Polans, Arthur S.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - The objective of this study was to determine whether resveratrol or a defined, reconstituted grape powder can attenuate the formation of new blood vessels in a mouse model of choroidal neovascularization (CNV). To accomplish this objective, C57BL/6J mice were randomized into control or treatment groups which received either resveratrol or grape powder by daily oral gavage, resveratrol or grape powder delivered ad libitum through the drinking water, or resveratrol by slow release via implanted osmotic pumps. A laser was used to rupture Bruch's membrane to induce CNV which was then detected in sclerochoroidal eyecups stained with antibodies against intercellular adhesion molecule-2. CNV area was measured using fluorescence microscopy and Image J software. Ad libitum delivery of both resveratrol and grape powder was shown to significantly reduce the extent of CNV by 68% and 57%, respectively. Parallel experiments conducted in vitro demonstrated that resveratrol activates p53 and inactivates Akt/protein kinase B in choroidal endothelial cells, contributing to its anti-proliferative and anti-migratory properties. In addition resveratrol was shown to inhibit the formation of endothelial cell networks, augmenting its overall anti-angiogenic effects. The non-toxic nature of resveratrol makes it an especially attractive candidate for the prevention and/or treatment of CNV.

AB - The objective of this study was to determine whether resveratrol or a defined, reconstituted grape powder can attenuate the formation of new blood vessels in a mouse model of choroidal neovascularization (CNV). To accomplish this objective, C57BL/6J mice were randomized into control or treatment groups which received either resveratrol or grape powder by daily oral gavage, resveratrol or grape powder delivered ad libitum through the drinking water, or resveratrol by slow release via implanted osmotic pumps. A laser was used to rupture Bruch's membrane to induce CNV which was then detected in sclerochoroidal eyecups stained with antibodies against intercellular adhesion molecule-2. CNV area was measured using fluorescence microscopy and Image J software. Ad libitum delivery of both resveratrol and grape powder was shown to significantly reduce the extent of CNV by 68% and 57%, respectively. Parallel experiments conducted in vitro demonstrated that resveratrol activates p53 and inactivates Akt/protein kinase B in choroidal endothelial cells, contributing to its anti-proliferative and anti-migratory properties. In addition resveratrol was shown to inhibit the formation of endothelial cell networks, augmenting its overall anti-angiogenic effects. The non-toxic nature of resveratrol makes it an especially attractive candidate for the prevention and/or treatment of CNV.

KW - Age-related macular degeneration

KW - Angiogenesis

KW - Choroidal neovascularization

KW - Grape constituents

KW - Natural products

KW - Resveratrol

UR - http://www.scopus.com/inward/record.url?scp=84912557427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912557427&partnerID=8YFLogxK

U2 - 10.3390/molecules191117578

DO - 10.3390/molecules191117578

M3 - Article

C2 - 25361423

AN - SCOPUS:84912557427

VL - 19

SP - 17578

EP - 17603

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 11

ER -